NSE - Delayed Quote INR

Supriya Lifescience Limited (SUPRIYA.NS)

629.00
-9.10
(-1.43%)
At close: 3:29:57 PM GMT+5:30
Loading Chart for SUPRIYA.NS
  • Previous Close 638.10
  • Open 621.00
  • Bid --
  • Ask --
  • Day's Range 615.00 - 640.35
  • 52 Week Range 330.00 - 842.00
  • Volume 173,262
  • Avg. Volume 341,447
  • Market Cap (intraday) 50.697B
  • Beta (5Y Monthly) 0.19
  • PE Ratio (TTM) 29.08
  • EPS (TTM) 21.63
  • Earnings Date --
  • Forward Dividend & Yield 0.80 (0.13%)
  • Ex-Dividend Date Sep 20, 2024
  • 1y Target Est 740.00

Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in anti-histamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, anti-malarial products, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, it also offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, the company is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessasion, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic, stem cell transplantation, and anti-migraine. The company was founded in 1987 and is headquartered in Mumbai, India.

www.supriyalifescience.com

448

Full Time Employees

March 31

Fiscal Year Ends

Recent News: SUPRIYA.NS

View More

Performance Overview: SUPRIYA.NS

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

SUPRIYA.NS
14.98%
S&P BSE SENSEX (^BSESN)
1.68%

1-Year Return

SUPRIYA.NS
70.85%
S&P BSE SENSEX (^BSESN)
9.74%

3-Year Return

SUPRIYA.NS
79.70%
S&P BSE SENSEX (^BSESN)
45.87%

5-Year Return

SUPRIYA.NS
49.41%
S&P BSE SENSEX (^BSESN)
151.10%

Compare To: SUPRIYA.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SUPRIYA.NS

View More

Valuation Measures

Annual
As of 5/8/2025
  • Market Cap

    51.20B

  • Enterprise Value

    50.39B

  • Trailing P/E

    29.46

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.82

  • Price/Book (mrq)

    5.67

  • Enterprise Value/Revenue

    7.66

  • Enterprise Value/EBITDA

    19.43

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    26.02%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    6.71B

  • Net Income Avi to Common (ttm)

    1.75B

  • Diluted EPS (ttm)

    21.63

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    843.14M

  • Total Debt/Equity (mrq)

    0.61%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: SUPRIYA.NS

View More

Company Insights: SUPRIYA.NS

Research Reports: SUPRIYA.NS

View More

People Also Watch